• Cambridge Nutritional Sciences published its annual report for the year ended March 31, 2026, citing weaker distributor demand in several regions.
• UK lab testing volumes rose, supported by direct-to-consumer channels; India also delivered strong growth through local partner expansion.
• Management reorganized sales and marketing in October 2025, adding a Customer Success team to lift partner support and conversion.
• UK operations were restructured in March 2026 to cut the cost base; headcount fell to 58 FTE from 76.
• Operational upgrades included a new LIMS, improved manufacturing yields, a new sample collection pack, and continued progress toward IVDR completion in 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cambridge Nutritional Sciences plc published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.